Log In
Print
BCIQ
Print
Print this Print this
 

Hylenex (rHuPH20)

Also known as: formerly Enhanze SC

  Manage Alerts
Collapse Summary General Information
Company Halozyme Therapeutics Inc.
DescriptionRecombinant human PH20 hyaluronidase enzyme
Molecular Target Hyaluronan
Mechanism of ActionDegrades hyaluronan
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$581.0M

$15.0M

$566.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today